Get my own profile
Public access
View all53 articles
0 articles
available
not available
Based on funding mandates
Co-authors
Xiaole Shirley LiuCEO, GV20 TherapeuticsVerified email at ds.dfci.harvard.edu
Jun S LiuProfessor of statistics, Harvard UniversityVerified email at stat.harvard.edu
Taiwen LiAssociate Professor, West China Hospital of Stomatology, Sichuan UniversityVerified email at scu.edu.cn
Jingxin FuResearch Scientist, Medical Oncology Department, Dana-Farber Cancer InstituteVerified email at ds.dfci.harvard.edu
Peng JiangStadtman Tenure-Track Investigator, National Cancer Institute, NIHVerified email at nih.gov
Xihao HuGV20 TherapeuticsVerified email at gv20therapeutics.com
Myles BrownEmil Frei III Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical SchoolVerified email at dfci.harvard.edu
Shengqing (Stan) GuThe University of Texas MD Anderson Cancer CenterVerified email at mdanderson.org
Avinash SahuUniversity of New Mexico Cancer Center & TumorAI.orgVerified email at salud.unm.edu
Jun LiCaltech, Stanford (previously), Michigan (current)Verified email at med.umich.edu
Deng Pan, Ph.D.Assistant Professor, Tsinghua UniversityVerified email at tsinghua.edu.cn
Sabina SignorettiProfessor, Brigham and Women's Hospital, Harvard Medical SchoolVerified email at bwh.harvard.edu
Jean-Christophe PignonPrincipal ScientistVerified email at jouncetx.com
Scott RodigProfessor of Pathology, Brigham & Women's HospitalVerified email at bwh.harvard.edu
Hui ShenVan Andel Research InstituteVerified email at vai.org
Vincent B. YoungUniversity of MichiganVerified email at umich.edu
Casey TheriotNC State UniversityVerified email at ncsu.edu
Chongzhi ZangAssociate Professor, University of VirginiaVerified email at virginia.edu
Cliff MeyerDana-Farber Cancer Institute and Harvard T.H. Chan School of Public HealthVerified email at jimmy.harvard.edu
Ruoxu DouDana-Farber Cancer InstituteVerified email at dfci.harvard.edu